Released Aug 11, 2021, after the close
10-Q filed Aug 12, 2021, 43 days after period end · 0001558370-21-011508
Q2 2021 · 10-Q
Revenue$0.00$0.00 — vs Q2 2020no prior Q1 2021 on file
Net Income-$5.13M-$5.13M N/M vs Q2 2020N/M vs Q1 2021
EPS Diluted-$0.56-$0.56 N/M vs Q2 2020N/M vs Q1 2021
Operating Income-$6,100,000N/M
Operating Cash Flowderived-$4,215,000N/M
Free Cash Flowderived-$4,153,000N/M
What the release said
The release
Same quarter
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$5.13M | -$2.17M | -$1.78M | -$1.85M |
| EPS Diluted | -$0.56 | -$0.58 | -$2.13 | -$0.16 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio Green Med Solution, Inc. · CIK 1130166 · Engraved from SEC EDGAR